Skip to main content
Top
Published in: Current Infectious Disease Reports 12/2023

27-10-2023 | Bursitis | Skin, Soft Tissue, Bone and Joint Infections (N Safdar and A Haleem, Section Editors)

Should We Tap That? Aspirates and Antibiotics: An Update on Septic Bursitis

Authors: Rachel Weihe, Mitchell C. Birt, Wissam El Atrouni

Published in: Current Infectious Disease Reports | Issue 12/2023

Login to get access

Abstract

Purpose of Review

Septic bursitis is a relatively common condition that causes substantial morbidity, but there is no universally accepted approach to management. We aim to evaluate recent literature with an eye toward recommended changes in the practice of bursal aspiration, surgical debridement, and antibiotic treatment.

Recent Findings

Authors of recent studies suggest that most patients with uncomplicated septic bursitis can be treated nonoperatively, perhaps even without aspiration of the bursal sac, and can achieve satisfactory clinical response with antibiotics alone. Surgical debridement has not been shown to be superior to nonoperative approaches but is recommended for complex or refractory cases. Optimal antibiotic route and duration is largely determined by severity of the presentation, but many authors favor transition to oral antibiotic therapy early where appropriate.

Summary

There remains considerable heterogeneity regarding the best management of septic bursitis, ranging from aggressive surgical debridement to isolated antibiotic treatment. Bursal aspiration can help to guide antimicrobial therapy but is not necessarily a requirement in making the diagnosis if patients show an adequate response to empiric antibiotics. Close follow-up after initial presentation for patients with proven or suspected septic bursitis is important to determine their clinical response and to further guide their management.
Literature
1.
go back to reference McAfee JH, Smith DL. Olecranon and prepatellar bursitis. Diagnosis and treatment. West J Med. 1988 Nov;149(5):607–10. PMID: 3074561; PMCID: PMC1026560. McAfee JH, Smith DL. Olecranon and prepatellar bursitis. Diagnosis and treatment. West J Med. 1988 Nov;149(5):607–10. PMID: 3074561; PMCID: PMC1026560.
9.
go back to reference • Charret L, Bart G, Hoppe E, Dernis E, Cormier G, Boutoille D, Le Goff B, Darrieutort-Laffite C. Clinical characteristics and management of olecranon and prepatellar septic bursitis in a multicentre study. J Antimicrob Chemother. 2021;76(11):3029–32. https://doi.org/10.1093/jac/dkab265. This study included a large cohort of septic bursitis patients with evaluation of surgical and antibiotic management strategies.CrossRefPubMed • Charret L, Bart G, Hoppe E, Dernis E, Cormier G, Boutoille D, Le Goff B, Darrieutort-Laffite C. Clinical characteristics and management of olecranon and prepatellar septic bursitis in a multicentre study. J Antimicrob Chemother. 2021;76(11):3029–32. https://​doi.​org/​10.​1093/​jac/​dkab265This study included a large cohort of septic bursitis patients with evaluation of surgical and antibiotic management strategies.CrossRefPubMed
20.
go back to reference Khodaee M. Common superficial bursitis. Am Fam Physician. 2017;95(4):224–31 PMID: 28290630.PubMed Khodaee M. Common superficial bursitis. Am Fam Physician. 2017;95(4):224–31 PMID: 28290630.PubMed
22.
25.
go back to reference • Beyde A, Thomas AL, Colbenson KM, Sandefur BJ, Kisirwan I, Mullan AF, et al. Efficacy of empiric antibiotic management of septic olecranon bursitis without bursal aspiration in emergency department patients. Acad Emerg Med. 2022;29(1):6–14. Epub 20211109. https://doi.org/10.1111/acem.14406. This is a larger cohort study evaluating outcomes with non-surgical management for septic bursitis. • Beyde A, Thomas AL, Colbenson KM, Sandefur BJ, Kisirwan I, Mullan AF, et al. Efficacy of empiric antibiotic management of septic olecranon bursitis without bursal aspiration in emergency department patients. Acad Emerg Med. 2022;29(1):6–14. Epub 20211109. https://​doi.​org/​10.​1111/​acem.​14406This is a larger cohort study evaluating outcomes with non-surgical management for septic bursitis.
26.
Metadata
Title
Should We Tap That? Aspirates and Antibiotics: An Update on Septic Bursitis
Authors
Rachel Weihe
Mitchell C. Birt
Wissam El Atrouni
Publication date
27-10-2023
Publisher
Springer US
Published in
Current Infectious Disease Reports / Issue 12/2023
Print ISSN: 1523-3847
Electronic ISSN: 1534-3146
DOI
https://doi.org/10.1007/s11908-023-00819-3

Other articles of this Issue 12/2023

Current Infectious Disease Reports 12/2023 Go to the issue

Skin, Soft Tissue, Bone and Joint Infections (N Safdar and A Haleem, Section Editors)

Next Steps: Studying Diabetic Foot Infections with Next-Generation Molecular Assays

Healthcare Associated Infections (ME Doll and B Rittmann, Section Editors)

Complex Outpatient Antimicrobial Therapy: Alternative Management Strategies and Outcomes

Antimicrobial Development and Drug Resistance (KC Claeys and J Smith, Section Editors)

Antibiotic Use at Hospital Discharge and Outpatient Antimicrobial Stewardship

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.